Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80
Organisation › Details

OrbiMed (Group)

OrbiMed is a leading healthcare investment firm, with over $14 billion in assets under management. OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, utilizing a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed maintains offices in New York City, San Francisco, Shanghai, Hong Kong, Mumbai and Herzliya. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and global team resources and support to help build world-class healthcare companies. *

 

Period Start 1989-01-01 established
Products Industry private equity
  Industry 2 LIFE SCIENCES
Person Person Khuong, Chau Q. (OrbiMed Advisors 201411 Private Equity Partner joined OrbiMed 2003)
     
Region Region New York, NY
  Country United States (USA)
  Street 767 Third Avenue
30th Floor
  City 10017 New York, NY
  Tel +1-212-739-6400
    Address record changed: 2020-12-02
     
Basic data Employees C: 51 to 100 (2019-08-22)
  Currency USD
  Annual sales 14,000,000,000 (assets, managed (2020) 2020-03-26)
     
    * Document for �About Section�: ReCode Therapeutics. (3/26/20). "Press Release: ReCode Therapeutics Raises $80 Million in Oversubscribed Series A Financing". Menlo Park, CA & Dallas, TX.
     
   
Record changed: 2021-05-24

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for OrbiMed (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Network in German Capital Region 650x80px




» top